Drug Database
Back to search

Japan· JP-1179017F2052

炭酸リチウム

A lithium product containing 炭酸リチウム, registered in Japan by 大正製薬, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

On Japan’s NHI price listATC N05AN01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalised炭酸リチウムATCN05AN01REGISTER NO.JP-1179017F2052PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about 炭酸リチウムAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lithium is registered in 15 of 19 countries.

Countries holding a registration under ATC N05AN01 (lithium), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 8 of them publish a price we can compare per daily dose
Search lithium products by name

Lithium · ATC N05AN01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
炭酸リチウム
Manufacturer
大正製薬
Country
Japan (JP)
ATC code
N05AN01
ATC class
Lithium
Defined daily dose
24 mmol, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

428 interactions on record for lithium.

Graded by severity as the source publishes them — 73 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lithium against other medicinesHow interaction checks work

Lithium · interactions on record

428 records

  • 73 severe
  • 250 moderate
  • 15 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

90 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lithium in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lithium products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Lithiumchlorid Lidco, Neurolepsin
  • Belgium · Camcolit
  • Bulgaria · Lithibalance
  • Cyprus · Plenur
  • Czechia · Lithium Carbonicum Slovakofarma, Lithium Chlorid Lco
  • Germany · Hypnorex Retard, Quilonum Retard
  • Denmark · Carblit, Litarex
  • Spain · Cloruro De Litio Lidco Netherlands, Plenur
  • Finland · Lito
  • France · Lithioderm, Lithium Granions
  • United Kingdom (Northern Ireland) · Camcolit, Li-Liquid
  • Greece · Milithin
  • Croatia · Litijev Karbonat Jgl, Litijev Klorid Lidco
  • Hungary · Liticarb
  • Ireland · Camcolit, Lithium Chloride Lidco Netherlands
  • Iceland · Litarex
  • Italy · Carbolithium, Litio Carbonato L.F.M.
  • Luxembourg · Camcolit, Oligosol
  • Netherlands · Camcolit, Carblit
  • Norway · Carblit, Lithium Chloride Lidco
  • Poland · Lithium Carbonicum Gsk
  • Portugal · Plenur, Priadel
  • Sweden · Carblit, Lithionit
  • Slovenia · Litijev Karbonat Lekarna Ljubljana
  • Slovakia · Lithium Carbonicum Slovakofarma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/28ad05bc-976a-4fbe-92cb-a4016929a4e5
GET /v1/drugs/28ad05bc-976a-4fbe-92cb-a4016929a4e5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "２００ｍｇ１錠",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1179017F2052",
  "category": "内用薬",
  "price_yen": 11.6,
  "generic_name": "炭酸リチウム",
  "product_name_jp": null,
  "therapeutic_class": "1179",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about lithium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console